Bio Path | BPTH - Dochód Netto





Dochód Netto Zmiana Data
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Baxter International USD 126M 141M 2026-06
Bio Path USD -270K 706K 2026-03
Cipla INR 7.89B 2.34B 2026-06
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -7.67M 64.51M 2026-03
CSL USD 401M 96.5M 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03